Elbasvir

• Background :

  Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A) . NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM. It exhibits potent inhibitory activity against a broad range of HCV genotypes. Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV. Identified as a potential inhibitor of SARS-CoV-2, responsible for COVID-19.

• Type :

  Chemical

• Purity :

  Greater than or equal to 98% (HPLC)

• Shipping Conditions :

  Room Temp

• Storage Conditions :

  Short Term Storage:+4C. Long Term Storage: -20C. Handling Advice: Protect from light. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.

• Calculated Molecular Weight :

  882

• Other Product Names :

  MK-8742

• Physical Properties :

  Lyophilized

• CAS Number :

  1370468-36-2